Accelerate to discover
Related topics
Easy and accurate cell counting in less than 20 seconds with C100 counter
Oct 16, 2020
Cell counters are tools for counting live and/or dead cells in a culture. Any researcher who works in a cell culture...
Automated fever & hypothermia detection
Oct 14, 2020
As one of the oldest clinical indicators of disease in mammals, temperature is a crucial parameter to monitor,...
Multi-modal molecular imaging driving pre-clinical research & pharmaceutical development
Oct 6, 2020
Multi-modal molecular imaging at Massachusetts General Hospital – driving pre-clinical research and patient pathways...
Developing tools for multiplex to single EV analysis pipelines
Sep 30, 2020
Extracellular vesicles (EVs) are lipid spheres released from cells. EVs express proteins and contain cargo that pertain...
IncuCyte webinar : clonal heterogeneity promotes metabolite exchange to support pancreatic tumor
Sep 25, 2020
Pancreatic ductaladenocarcinoma (PDA) is the third leading cause of cancer related death in the United States,...
Why ventilator is so important in the battle against COVID-19?
Sep 21, 2020
The COVID-19 has caused shortages of medical devices in many countries, especially ventilators. Many companies around...
Imaging Performance of a multimodal module to enhance preclinical irradiator capabilities
Sep 15, 2020
Upgrading an existing irradiator with such a multi-modal imaging device is a reasonable investment in laboratories...
Are you still using traditional methodologies for your Oncology cell metabolism studies?
Sep 10, 2020
In this infographic, learn about the challenges experienced by scientists in analysing cellular metabolism and how...
Feb 12, 2019
If you are currently measuring the killing potency of an immunotherapy targeting liquid cancer cells using traditional endpoint assays such as Cr51 release and LDH assays, you are missing key elements of tumor cytotoxicity. Cancer-killing effectors do not always kill the targets at a constant pace. Have you optimized the incubation time of the effector/target co-culture and collect the readout at the peak of each cytotoxicity reaction.
We are excited to share the latest application note for xCELLigence Real Time Cell Analysis: "Evaluating Functional Potency of Immunotherapies Targeting Tumors of B Cell Origin." The application note explains the principle of measuring the cytotoxicity of liquid tumors such as lymphoma, leukemia or myeloma continuously, in real-time and with unprecedented details. Key benefits include:
• Radiation-free
• Substantially reduced workload - just add effectors to targets and you are all set
• Continuous in real-time
• Assay windows spanning minutes to days
• Low, physiologically relevant effector:target ratios
Related technologies: Real-time, label free cell analysis
Get more info
Brand profile
ACEA manufactures xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
More info at:
www.aceabio.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
